发明授权
US08436015B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
有权
胰高血糖素受体拮抗剂化合物,含有这些化合物的组合物和使用方法
- 专利标题: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
- 专利标题(中): 胰高血糖素受体拮抗剂化合物,含有这些化合物的组合物和使用方法
-
申请号: US13063820申请日: 2009-09-10
-
公开(公告)号: US08436015B2公开(公告)日: 2013-05-07
- 发明人: Songnian Lin , Christian P. Stevenson , Emma R. Parmee , Libo Xu , Xibin Liao , Edward Metzger , Rui Liang , Fengqi Zhang , John E. Stelmach
- 申请人: Songnian Lin , Christian P. Stevenson , Emma R. Parmee , Libo Xu , Xibin Liao , Edward Metzger , Rui Liang , Fengqi Zhang , John E. Stelmach
- 申请人地址: US NJ Rahway
- 专利权人: Merck Sharp & Dohme Corp.
- 当前专利权人: Merck Sharp & Dohme Corp.
- 当前专利权人地址: US NJ Rahway
- 代理商 Anna L. Cocuzzo; John C. Todaro
- 国际申请: PCT/US2009/056436 WO 20090910
- 国际公布: WO2010/030722 WO 20100318
- 主分类号: A01N43/42
- IPC分类号: A01N43/42 ; A61K31/47 ; C07D215/00
摘要:
Glucagon receptor antagonist compounds of formula I are disclosed: The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.